Swiss authorities have agreed to extradite a Chinese researcher to the United States, where he is accused of conducting corporate espionage against British pharmaceutical company GlaxoSmithKline (GSK).
U.S. prosecutors have indicted Xue Gongda, a Swiss resident, for conspiring with his sister, Xue Yu, a biochemist who worked at a GSK facility in Pennsylvania, to steal information about products GSK was developing to fight cancer, including antibodies that bind to tumor cells.
